Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Breda Genetics srl | RCV001254911 | SCV001371693 | likely pathogenic | Kleefstra syndrome 1 | 2020-06-23 | criteria provided, single submitter | clinical testing | The variant c.3627_3633dup (p.Val1212Argfs*32) creates a shift in the reading frame which is predicted to result in a premature stop codon 32 amino acids downstream, which is likely to result in a truncated protein or protein loss due to nonsense-mediated messenger decay (NMD). This variant has not been reported in dbSNP, gnomAD, 1000 Genomes, NHLBI Exome Sequencing Project (ESP) or ClinVar. Upstream of the identified variant, an in-frame deletion, c.3583_3594del (p.Val1195_Phe1198del) (Variation ID: 435046), and a missense variant, c.3589C> T (p.Arg1197Trp) (Variation ID: 65737), have been reported as likely pathogenic. Partially overlapping with our identified variant, an in-frame duplication , c.3626_3631dup (p.Pro1209_Val1210dup) (Variation ID: 42134), is reported as likely pathogenic. Downstream of our identified variant, nonsense variants with pathogenic significance have also been reported: c.3649C> T (p.Gln1217 *) (Variation ID: 489228) and c.3709C> T (p.Gln1237 *) (Variation ID: 802554). |